Article

AAO LIVE: Study compares dry eye disease in adult, pediatric populations in IRIS registry

Author(s):

During a presentation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago, Vivian Paraskevi Douglas, MD, DVM, MBA, MSc, detailed a study in which investigators used the extensive data in the American Academy of Ophthalmology IRIS Registry to study the difference between the pediatric and adult populations.

The American Academy of Ophthalmology is holding its annual meeting at McCormick Place in Chicago. The center's North Building is shown. (Image courtesy of McCormick Place)

The American Academy of Ophthalmology is holding its annual meeting at McCormick Place in Chicago. The center's North Building is shown. (Image courtesy of McCormick Place)

A study of dry eye disease (DED) in children found that the average age of onset of DED is at 12.51 years compared with the average of 61.06 years in adults. The highest prevalence in children was seen between 12 to 15 years of age, according to lead author Vivian Paraskevi Douglas, MD, DVM, MBA, MSc, and colleagues from Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston.

Although DED is highly prevalent in adults, with rates ranging from 5% to as high as 50%, little is known about the disorder in pediatric patients, which sparked the interest in this study.

IRIS Registry data

Vivian Paraskevi Douglas, MD, DVM, MBA, MSc

Vivian Paraskevi Douglas, MD, DVM, MBA, MSc

The investigators used the extensive data in the American Academy of Ophthalmology Intelligent Research in Sight (IRIS) Registry to study the difference between the pediatric and adult populations.

Almost 5 million patients in the IRIS Registry had received at least one diagnosis of DED between 2013 and 2019; of those, 203,171 were children under 18 years of age and 4,592,808 were adults.

Douglas and associates collected data on biologic sex, race, ethnicity, and US geographic region of residence.

The data breakdown showed that DED was diagnosed in females significantly more often compared with males. More cases of DED were diagnosed among white adults and children compared with Asian and Black/African American patients. More cases were diagnosed among non-Hispanic and Latino children and adults compared with Hispanic/Latino patients, and more cases were diagnosed in patients in both age groups in the North Central and Northeast regions of the US.

Among the pediatric patients, DED had higher prevalence rates in those with refractive errors and eyelid/conjunctival disorders, the authors reported.

Regarding seasons, springtime had the highest prevalence of DED and winter the lowest among the pediatric population.

“Until recently, pediatric dry eye disease has been an under-recognized disease due to diagnostic limitations and challenges of interpreting the symptoms in children,” Douglas and her mentor, Aisha Traish, MD, concluded. “We are excited about the potential for big data to provide insight that informs our care for this segment of the population.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.